[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367886-105":59,"doc-detail-367886-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","possible-roles-for-purinergic-receptor-p2rx4-in-breast-and-prostate-cancers-review","Possible Roles for Purinergic Receptor P2RX4 in Breast and Prostate Cancers - review","","Purinergic receptor P2RX4 is presented as a key contributor to the malignant behavior of breast and prostate cancers. The receptor is described as being upregulated in these tumors and promoting progression through pathways involving EMT, autophagy, and the release of pro-malignant lysosomal contents. P2RX4 is also linked to cell signaling networks through interactions with oncogenes and tumor suppressors. The review further notes that P2RX4 genetic variants associate with higher cancer risk and highlights targeting P2RX4 as a therapeutic direction, including antibodies, CAR-T cells, and small-molecule inhibitors. Additional research is required to clarify molecular drivers and enable effective, safe clinical translation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/possible-roles-for-purinergic-receptor-p2rx4-in-breast-and-prostate-cancers-review/367886/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/possible-roles-for-purinergic-receptor-p2rx4-in-breast-and-prostate-cancers-review/367886.png","ImageObject",300,407,{"name":92,"@type":93},"Bulrr","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":14},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does P2RX4 contribute to breast and prostate cancer progression?","Question",{"text":112,"@type":113},"P2RX4 is upregulated in these malignancies and promotes tumor progression through mechanisms involving EMT, autophagy, and the release of pro-malignant lysosomal contents.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What cellular signaling processes are associated with P2RX4 in cancer?",{"text":117,"@type":113},"P2RX4 influences signaling pathways by interacting with oncogenes and tumor suppressors, which can affect oncogenic and physiological processes.",{"name":119,"@type":110,"acceptedAnswer":120},"What therapeutic strategies are suggested for targeting P2RX4?",{"text":121,"@type":113},"Targeting P2RX4 is highlighted as promising, with potential approaches including antibody therapy, CAR-T cell therapies, and small-molecule inhibitors.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367886,1792219749,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":14,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909892115043,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Review  \nPossible Roles for Purinergic Receptor P2RX4 in Breast and Prostate Cancers  \nWalfred H. J. Ho 1 and Kong-Peng Lam 2,3,4, *  \nAcademic Editor: Kazuhiko Kuwahara  \nReceived: 27 August 2025  \nRevised: 12 September 2025  \nAccepted: 13 September 2025  \nPublished: 17 September 2025  \nCitation: Ho, W.H.J.; Lam, K.-P. Possible Roles for Purinergic Receptor P2RX4 in Breast and Prostate Cancers. Int. J. Mol. Sci. 2025, 26, 9043. [https://](https://)[ ](https://)[doi.org/10.3390/ijms26189043](doi.org/10.3390/ijms26189043)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 School of Physical and Mathematical Sciences, Nanyang Technological University, Singapore 637371, Singapore; [hohs0003@e.ntu.edu.sg](hohs0003@e.ntu.edu.sg)  \n2 Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, \\#04-06 Immunos, Singapore 138648, Singapore  \n3 Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore  \n4 School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore 637551, Singapore  \n* Correspondence: [lam_kong_peng@a-star.edu.sg](lam_kong_peng@a-star.edu.sg)  \nAbstract  \nThe purinergic receptor P2RX4 contributes to the malignant behavior of breast and prostate cancers. It is upregulated in these malignancies and promotes tumor progression through mechanisms involving EMT, autophagy, and the release of pro-malignant lysosomal contents. P2RX4 also influences cellular signaling pathways by interacting with oncogenes and tumor suppressors. Certain genetic variants of P2RX4 are associated with an increased risk of developing these cancers. Hence, targeting P2RX4 represents a promising therapeutic approach, with potential strategies including antibody and CAR-T cell therapies and the development of small-molecule inhibitors. Further investigation is needed to fully elucidate the molecular mechanisms by which P2RX4 drives cancer progression and to translate these findings into effective and safe clinical therapies.  \nKeywords: purinergic signaling; tumor; autophagy; lysosomes  \n1. Introduction  \nCancer is a leading cause of death globally and is associated with abnormal and uncontrolled cell growth and the spread of malignant cells to healthy tissues. One in six deaths worldwide is caused by cancer [1], and this phenomenon has led to many studies into this complex disease. The complexity of cancer lies in both the causes and mechanisms underlying oncogenesis and disease progression. By understanding the etiology of cancers, we can find better ways to manage and treat these ailments.  \nFrom a study point of view, healthy and cancerous cells can be sequenced to identify their genetic defects, particularly in oncogenes or tumor suppressor genes [2] . Oncogenes are genes that have the potential to cause cancer through gain-of-function mutations or overexpression. Tumor suppressor genes, such as p53, which regulates cell replication [2,3], lose their normal functions when mutated, and the mutated variant contributes to the etiology and/or progression of cancer. Hence, the identification of genetic aberrationsin oncogenes and tumor suppressor genes could contribute to better understanding and treatment of cancer.  \nThough not considered as oncogenes or tumor suppressor genes, the P2X family of receptors has been shown to play physiologically important roles in cell signaling [4] and  \ncould contribute to the progression of cancer. P2RX4, a member of this family, has been implicated in breast and prostate cancers [5–7] and shown to promote tumor progression and aggressiveness [7] . Becau","cbCaif2zxs4XIqkK","https://ap.wps.com/l/cbCaif2zxs4XIqkK","pdf",2248921,14,"English","# Abstract\n# Introduction\n# Purinergic Receptors\n## P2X receptor family and purinergic signaling","[{\"question\":\"How does P2RX4 contribute to breast and prostate cancer progression?\",\"answer\":\"P2RX4 is upregulated in these malignancies and promotes tumor progression through mechanisms involving EMT, autophagy, and the release of pro-malignant lysosomal contents.\"},{\"question\":\"What cellular signaling processes are associated with P2RX4 in cancer?\",\"answer\":\"P2RX4 influences signaling pathways by interacting with oncogenes and tumor suppressors, which can affect oncogenic and physiological processes.\"},{\"question\":\"What therapeutic strategies are suggested for targeting P2RX4?\",\"answer\":\"Targeting P2RX4 is highlighted as promising, with potential approaches including antibody therapy, CAR-T cell therapies, and small-molecule inhibitors.\"}]","Possible Roles for Purinergic Receptor P2RX4 in Breast and Prostate Cancers - review | PDF",1790173167,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e912ad0f002aa410826f027402a935e3.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a828ba230bd1656ffa2a30f598972a69.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b146bc0a8e7b098d2ad227f19dcd4e1.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4eb975c6e582f706e6ae524558416ef6.webp",980,1385]